InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,509.01
(
0.00%
)
US TECH 100
19,446.00
(
-0.17%
)
Dow Jones
39,331.85
(
0.00%
)
Brent Oil
86.18
(
-0.31%
)
Bitcoin
60,201.70
(
-2.94%
)
Post# of 703468
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

alphapuppy

Send PM Follow Ignore
Followers 32
Posts 491
Boards Moderated 0
Alias Born 10/11/2007

alphapuppy

Re: Al4door post# 100396

Monday, 02/06/2017 10:32:56 AM

Monday, February 06, 2017 10:32:56 AM

Post# of 703468
To explain the latest press release, in simple terms, transparently, is that the trial is succeeding.

Their primary endpoint, Progression free survival, has the number of events necessary for the trail to be analyzed. Based on historical, data sets, regarding the length of time that it took to achieve the number of events, lead me to believe that this will be a statistically significant result favoring the experimental treatment arm.

Overall survival, nearly always takes longer to event out then does progression free survival.

It would appear that there still may be time to benefit from the low capitalization of the company at this time, Prior to more Data analysis and review.

It looks like they might be shooting for a ASCO presentation.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News
InvestorsHub NewsWire

FEATURED Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • Jul 3, 2024 9:00 AM

EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM

BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM

NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM

Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM

VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM

Start posting your company's news
Only $200 per official company press release!